AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30010353 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension Tamer (TT) guided BAM sessions for 15-min intervals twice daily
Number of subjects: 64
Study 28768474 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg vaginal progesterone
Number of subjects: 41
Study 28768474 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone treatment (meta-analysis)
Number of subjects: 41
Study 26220020 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga program for 12 weeks
Number of subjects: 0
Study 26220020 — intervention group
Group type: COMPARATOR
Intervention: Control group (no yoga exercise)
Number of subjects: 0
Study 24124750 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic extralevator abdominoperineal excision (LELAPE)
Number of subjects: 35
Study 24124750 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic abdominoperineal excision (LAPE)
Number of subjects: 35
Study 20624257 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron (200 mg of iron sucrose) and recombinant human erythropoietin‐β (3000 IU)
Number of subjects: 108
Study 20624257 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 108
Study 19057246 — intervention group
Group type: EXPERIMENTAL
Intervention: IP‐CHA spacers
Number of subjects: 88
Study 19057246 — intervention group
Group type: COMPARATOR
Intervention: Autogenous bone spacers
Number of subjects: 88
Study 16466883 — intervention group
Group type: EXPERIMENTAL
Intervention: Behçet's disease with ocular involvement
Number of subjects: 51
Study 16466883 — intervention group
Group type: EXPERIMENTAL
Intervention: Behçet's disease without ocular involvement
Number of subjects: 51
Study 16466883 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 51
Study 14714012 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC 400 mg, clarithromycin 250 mg and metronidazole 500 mg regimen, all drugs given twice daily for 7 days
Number of subjects: 146
Study 14714012 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced regimen with RBC, clarithromycin and metronidazole
Number of subjects: 146
Study 10933004 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel materials
Number of subjects: 4
Study 10933004 — intervention group
Group type: COMPARATOR
Intervention: Foam materials
Number of subjects: 4
Study 8780106 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressive treatment (prednisolone plus azathioprine)
Number of subjects: 11
Study 8780106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 1344473 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine 150 mg twice daily
Number of subjects: 120
Study 1344473 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (control) twice daily
Number of subjects: 120
Study 1344473 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine 300 mg once daily
Number of subjects: 120
Study 6421560 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined regimen of insulin and sulphonylurea (glibenclamide) for ten days, followed by ten days of insulin alone, followed by six months of combined treatment
Number of subjects: 16
Study 6421560 — intervention group
Group type: COMPARATOR
Intervention: Insulin alone
Number of subjects: 16
Study 6421560 — intervention group
Group type: EXPERIMENTAL
Intervention: Renewed combined treatment with sulphonylurea and insulin
Number of subjects: 16
Study 6421560 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with sulphonylurea and insulin
Number of subjects: 16
Study 31490254 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% inspired intraoperative oxygen
Number of subjects: 4481
Study 31490254 — intervention group
Group type: COMPARATOR
Intervention: 30% inspired intraoperative oxygen
Number of subjects: 4481
Study 31103101 — intervention group
Group type: EXPERIMENTAL
Intervention: IASTM
Number of subjects: 60
Study 31103101 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching
Number of subjects: 60
Study 31103101 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 28683243 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 grams of protein distributed across 2 isoenergetic carbohydrate-containing beverages (15 and 240 min postexercise) with varying amounts of protein (0 + 15 g, 5 + 10 g, 10 + 5 g, and 15 + 0 g)
Number of subjects: 35
Study 26451374 — intervention group
Group type: EXPERIMENTAL
Intervention: 12‐hour exposure in a normobaric hypoxic chamber
Number of subjects: 37
Study 23932244 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga therapy (60-min sessions weekly for 8 weeks)
Number of subjects: 49
Study 23932244 — intervention group
Group type: COMPARATOR
Intervention: Control group (weekly regular day-care program)
Number of subjects: 49
Study 21897841 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual-based group intervention
Number of subjects: 81
Study 21897841 — intervention group
Group type: COMPARATOR
Intervention: Leaflet control condition
Number of subjects: 81
Study 20043564 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectum cleaning with 10% povidone-iodine
Number of subjects: 100
Study 20043564 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rectum cleaning)
Number of subjects: 100
Study 17764454 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help leaflet (moderate group)
Number of subjects: 1175
Study 17764454 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured help from a continence nurse (severe group)
Number of subjects: 1175
Study 17764454 — intervention group
Group type: COMPARATOR
Intervention: No intervention (mild group)
Number of subjects: 1175
Study 17764454 — intervention group
Group type: COMPARATOR
Intervention: No intervention (moderate group)
Number of subjects: 1175
Study 15071842 — intervention group
Group type: EXPERIMENTAL
Intervention: Nootropil 70 mg/kg daily
Number of subjects: 80
Study 15071842 — intervention group
Group type: EXPERIMENTAL
Intervention: Nootropil 40 mg/kg daily
Number of subjects: 80
Study 15071842 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 80
Study 11408983 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical phenytoin sodium
Number of subjects: 47
Study 11408983 — intervention group
Group type: COMPARATOR
Intervention: DuoDerm dressings
Number of subjects: 47
Study 11408983 — intervention group
Group type: COMPARATOR
Intervention: Triple antibiotic ointment
Number of subjects: 47
Study 9505252 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Neural Networks (ANN) classification
Number of subjects: 15
Study 9505252 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal net with three variables (peak VO2 at high velocity, hand force on the rim at low velocity, push angle at high velocity)
Number of subjects: 15
Study 7829769 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous L-tryptophan (TRP)
Number of subjects: 32
Study 7829769 — intervention group
Group type: COMPARATOR
Intervention: Matched healthy controls
Number of subjects: 32
Study 3341324 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral positioning (right and left)
Number of subjects: 18
Study 3341324 — intervention group
Group type: COMPARATOR
Intervention: Supine positioning
Number of subjects: 18
Study 31385031 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential outcomes procedure (DOP)
Number of subjects: 0
Study 31385031 — intervention group
Group type: COMPARATOR
Intervention: Non-differential outcomes procedure (NOP)
Number of subjects: 0
Study 31427312 — intervention group
Group type: EXPERIMENTAL
Intervention: DDI alerts implemented in EMM system
Number of subjects: 3360
Study 31427312 — intervention group
Group type: COMPARATOR
Intervention: EMM system without DDI alerts
Number of subjects: 3360
Study 27875061 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycemic control target of 140 mg/dL
Number of subjects: 164
Study 27875061 — intervention group
Group type: COMPARATOR
Intervention: Glycemic control target of 180 mg/dL
Number of subjects: 164
Study 25522919 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided corticosteroid injection (1 ml containing 40 mg methylprednisolone acetate and 10 mg lidocaine hydrochloride)
Number of subjects: 55
Study 25522919 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 55
Study 25522919 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided corticosteroid injection
Number of subjects: 55
Study 24022261 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly iron supplements (200 mg ferrous sulphate containing 63 mg of elemental iron) for 24 weeks
Number of subjects: 352
Study 24022261 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly iron supplements (200 mg ferrous sulphate containing 63 mg of elemental iron) for 12 weeks
Number of subjects: 352
Study 24022261 — intervention group
Group type: COMPARATOR
Intervention: No iron supplements
Number of subjects: 352
Study 21375099 — intervention group
Group type: EXPERIMENTAL
Intervention: Group N (negative words)
Number of subjects: 232
Study 21375099 — intervention group
Group type: COMPARATOR
Intervention: Group P (positive words)
Number of subjects: 232
Study 18094675 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 1513
Study 18094675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1513
Study 17312588 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia femoral heads
Number of subjects: 60
Study 17312588 — intervention group
Group type: COMPARATOR
Intervention: Co-Cr-Mo femoral heads
Number of subjects: 60
Study 12943123 — intervention group
Group type: COMPARATOR
Intervention: Splint for less than 6 hours per day
Number of subjects: 43
Study 12943123 — intervention group
Group type: EXPERIMENTAL
Intervention: Splint for 6 to 12 hours per day
Number of subjects: 43
Study 10698828 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin plus haloperidol
Number of subjects: 39
Study 10698828 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol plus placebo
Number of subjects: 39
Study 9068511 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiography after treatment with thrombolytics
Number of subjects: 0
Study 9068511 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional death rate due to stroke
Number of subjects: 0
Study 9068511 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cardiovascular death rates
Number of subjects: 0
Study 9068511 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple linear regression analysis
Number of subjects: 0
Study 7513437 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg/die
Number of subjects: 34
Study 7513437 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg/die
Number of subjects: 34
Study 7513437 — intervention group
Group type: COMPARATOR
Intervention: Placebo (first year), then Finasteride 5 mg/die (second year)
Number of subjects: 34
Study 3092893 — intervention group
Group type: EXPERIMENTAL
Intervention: ethinyl oestradiol combined with polyoestradiol phosphate
Number of subjects: 30
Study 3092893 — intervention group
Group type: EXPERIMENTAL
Intervention: estramustine phosphate
Number of subjects: 30
Study 3092893 — intervention group
Group type: COMPARATOR
Intervention: bilateral orchiectomy
Number of subjects: 30
Study 30206095 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing for people with aphasia (SPA) intervention - 10 group sessions plus a resource booklet
Number of subjects: 48
Study 30206095 — intervention group
Group type: COMPARATOR
Intervention: Control - resource booklet only
Number of subjects: 48
Study 25808116 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g/day of milled flaxseed
Number of subjects: 34
Study 25808116 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g/day of milled flaxseed
Number of subjects: 34
Study 25808116 — intervention group
Group type: EXPERIMENTAL
Intervention: All flaxseed doses
Number of subjects: 34
Study 25808116 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g/day of milled flaxseed
Number of subjects: 34
Study 25808116 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses
Number of subjects: 34
Study 24906040 — intervention group
Group type: EXPERIMENTAL
Intervention: RG1068-stimulated MRCP
Number of subjects: 258
Study 24906040 — intervention group
Group type: COMPARATOR
Intervention: MRCP
Number of subjects: 258
Study 24906040 — intervention group
Group type: EXPERIMENTAL
Intervention: RG1068
Number of subjects: 258
Study 24906040 — intervention group
Group type: COMPARATOR
Intervention: ERCP
Number of subjects: 258
Study 22327109 — intervention group
Group type: EXPERIMENTAL
Intervention: Subpleural analgesia
Number of subjects: 42
Study 22327109 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural analgesia
Number of subjects: 42
Study 20816030 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical trial participants with ADHD
Number of subjects: 393
Study 20816030 — intervention group
Group type: COMPARATOR
Intervention: Community sample adults with ADHD
Number of subjects: 393
Study 20816030 — intervention group
Group type: COMPARATOR
Intervention: Excluded community sample adults with ADHD
Number of subjects: 393
Study 18528796 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemetric group (with further telemonitoring support)
Number of subjects: 200
Study 18528796 — intervention group
Group type: COMPARATOR
Intervention: Control group (without contact to clinic)
Number of subjects: 200
Study 16042224 — intervention group
Group type: EXPERIMENTAL
Intervention: IFNbeta‐1a (Avonex) once weekly
Number of subjects: 76
Study 16042224 — intervention group
Group type: EXPERIMENTAL
Intervention: IFNbeta three times weekly (Rebif and Betaferon)
Number of subjects: 76
Study 16042224 — intervention group
Group type: EXPERIMENTAL
Intervention: Glatiramer acetate (Copaxone)
Number of subjects: 76
Study 16042224 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment with immunomodulatory drugs (IDs)
Number of subjects: 76
Study 12183255 — intervention group
Group type: EXPERIMENTAL
Intervention: 1263W94 (100, 200, or 400 mg three times a day, or 600, 900, or 1,200 mg twice a day)
Number of subjects: 0
Study 12183255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10624380 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg, three times daily for 24 weeks
Number of subjects: 119
Study 10624380 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules, three times daily for 24 weeks
Number of subjects: 119
Study 10624380 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 119
Study 7670587 — intervention group
Group type: EXPERIMENTAL
Intervention: Pump cavernosometry (criterion I)
Number of subjects: 123
Study 7670587 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaco‐cavernosometry (criterion II)
Number of subjects: 123
Study 7670587 — intervention group
Group type: EXPERIMENTAL
Intervention: All four tests (criteria I)
Number of subjects: 123
Study 7670587 — intervention group
Group type: EXPERIMENTAL
Intervention: All four tests (criteria II)
Number of subjects: 123
Study 7670587 — intervention group
Group type: COMPARATOR
Intervention: Sequence of tests
Number of subjects: 123
Study 7670587 — intervention group
Group type: EXPERIMENTAL
Intervention: Pump cavernosometry, pharmaco‐cavernosometry, gravity cavernosometry, intracavernous pressure drop test
Number of subjects: 123
Study 2258339 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin (400 mg, iv, 8-hourly) for 5-30 days
Number of subjects: 71
Study 2258339 — intervention group
Group type: COMPARATOR
Intervention: Imipenem (1 g, iv, 8-hourly) for 5-30 days
Number of subjects: 71
Study 2258339 — intervention group
Group type: EXPERIMENTAL
Intervention: Pefloxacin
Number of subjects: 71
Study 2258339 — intervention group
Group type: COMPARATOR
Intervention: Imipenem
Number of subjects: 71
Study 233177 — intervention group
Group type: EXPERIMENTAL
Intervention: Clostridium Welchii Type C antitoxin
Number of subjects: 0
Study 233177 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31959342 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose radium-223 (55 kBq/kg every 4 weeks for six cycles)
Number of subjects: 391
Study 31959342 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose radium-223 (88 kBq/kg every 4 weeks for six cycles)
Number of subjects: 391
Study 31959342 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-schedule radium-223 (55 kBq/kg every 4 weeks for 12 cycles)
Number of subjects: 391
Study 31959342 — intervention group
Group type: COMPARATOR
Intervention: High-dose vs Standard-dose
Number of subjects: 391
Study 31959342 — intervention group
Group type: COMPARATOR
Intervention: Extended-schedule vs Standard-schedule
Number of subjects: 391
Study 31959342 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose radium-223
Number of subjects: 391
Study 31959342 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose radium-223
Number of subjects: 391
Study 31959342 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-schedule radium-223
Number of subjects: 391
Study 31204818 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-Web Internet-based parenting program
Number of subjects: 75
Study 31204818 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 75
Study 28403383 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 44
Study 28403383 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine
Number of subjects: 44
Study 28403383 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 28403383 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine and Varenicline
Number of subjects: 44
Study 28403383 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers
Number of subjects: 44
Study 25840436 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy relationships program for eighth graders (adapted from the Fourth R program for ninth graders)
Number of subjects: 1012
Study 25840436 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1012
Study 23891275 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone 30mg daily
Number of subjects: 129
Study 23891275 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1000mg daily
Number of subjects: 129
Study 21349878 — intervention group
Group type: EXPERIMENTAL
Intervention: US and CD-guided mini-surgery (scraping) outside the ventral tendon
Number of subjects: 103
Study 21349878 — intervention group
Group type: COMPARATOR
Intervention: Open treatment with a scalpel
Number of subjects: 103
Study 21349878 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous treatment with a needle
Number of subjects: 103
Study 18787997 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated Charcoal (AC) at 1 hour after ingestion
Number of subjects: 9
Study 18787997 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated Charcoal (AC) at 2 hours after ingestion
Number of subjects: 9
Study 18787997 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated Charcoal (AC) at 3 hours after ingestion
Number of subjects: 9
Study 18787997 — intervention group
Group type: COMPARATOR
Intervention: Control (no AC)
Number of subjects: 9
Study 17715118 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 900 mg injection 1 hour before and immediately after contrast medium injection, plus hydration
Number of subjects: 87
Study 17715118 — intervention group
Group type: COMPARATOR
Intervention: Hydration only
Number of subjects: 87
Study 15049961 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (50 mg/day)
Number of subjects: 10
Study 15049961 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 10
Study 12612144 — intervention group
Group type: EXPERIMENTAL
Intervention: Campbell's Condensed Tomato Soup (CS) - 35 +/- 1 mg lycopene/d
Number of subjects: 60
Study 12612144 — intervention group
Group type: EXPERIMENTAL
Intervention: Campbell's Ready To Serve Tomato Soup (RTS) - 23 +/- 1 mg lycopene/d
Number of subjects: 60
Study 12612144 — intervention group
Group type: EXPERIMENTAL
Intervention: V8 Vegetable Juice (V8) - 25 +/- 1 mg lycopene/d
Number of subjects: 60
Study 12612144 — intervention group
Group type: COMPARATOR
Intervention: All groups during washout period
Number of subjects: 60
Study 12612144 — intervention group
Group type: COMPARATOR
Intervention: All groups after treatment
Number of subjects: 60
Study 10373348 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose recombinant human insulin-like growth factor-I (rhIGF-I; 1.5 microg/kg/h)
Number of subjects: 5
Study 10373348 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose recombinant human insulin-like growth factor-I (rhIGF-I; 9.0 microg/kg/h)
Number of subjects: 5
Study 10373348 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 5
Study 7673863 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood matching at encoding and retrieval (Experiment 3)
Number of subjects: 0
Study 7673863 — intervention group
Group type: COMPARATOR
Intervention: Mood differing at encoding and retrieval (Experiments 1 and 2)
Number of subjects: 0
Study 2405140 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute Illness Observation Scales (AIOS) teaching film and booklet
Number of subjects: 369
Study 2405140 — intervention group
Group type: COMPARATOR
Intervention: 3-point global scoring system (Control)
Number of subjects: 369
Study 6770399 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methadone (up to 10 mg)
Number of subjects: 0
Study 31735137 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia
Number of subjects: 4181
Study 31735137 — intervention group
Group type: EXPERIMENTAL
Intervention: Shunting
Number of subjects: 4181
Study 31735137 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral high-grade carotid stenosis or occlusion
Number of subjects: 4181
Study 31735137 — intervention group
Group type: EXPERIMENTAL
Intervention: More severe neurological deficit (mRS, 3-5 versus 0-2)
Number of subjects: 4181
Study 27995731 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin isophane
Number of subjects: 50
Study 27995731 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 50
Study 27995731 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens after 3 days
Number of subjects: 50
Study 27070903 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (1010 cfu per day) for three weeks
Number of subjects: 16
Study 27070903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16